Lysosomal disorders of the nervous system

Research output: Chapter in Book/Report/Conference proceedingChapter

3 Citations (Scopus)

Abstract

This chapter describes storage disorders, defines the key pathogenic features affecting neurons in these diseases, and discusses the links between the storage disorders and known functions of the greater lysosomal system. The classification of lysosomal storage disorders can be based on their clinicopathological features or their defective proteins. The molecular causes of lysosomal storage disorders are far more complex than the simple absence of an individual lysosomal enzyme and include defects in a wide variety of soluble and transmembrane proteins, some of which lack any known enzyme activity. Neurons undergoing lysosomal storage, demonstrate the presence of abnormal storage bodies, principally in perikarya and in larger dendrites. Another area of speculation in terms of pathogenic mechanisms affecting neurons in storage diseases involves ganglioside distribution in diseased cells and the possibility that the endosomal-lysosomal (E/L) system defect leads to an abnormal distribution of specific glycosphingolipids (GSLs) in internal membranes of cells. Changes in the GSL constituents of intracellular membranes may be due to the catabolic defects inherent in lysosomal diseases. Two other mechanisms that are emerging as critical players in the development of neurological disease in storage disorders are apoptosis and inflammation.

Original languageEnglish (US)
Title of host publicationNeurobiology of Disease
PublisherElsevier Inc.
Pages1-18
Number of pages18
ISBN (Print)9780120885923
DOIs
StatePublished - 2007

Fingerprint

Nervous System Diseases
Glycosphingolipids
Neurons
Gangliosidoses
Intracellular Membranes
Enzymes
Dendrites
Proteins
Cell Membrane
Apoptosis
Inflammation

ASJC Scopus subject areas

  • Dentistry(all)
  • Medicine(all)

Cite this

Lysosomal disorders of the nervous system. / Walkley, Steven U.

Neurobiology of Disease. Elsevier Inc., 2007. p. 1-18.

Research output: Chapter in Book/Report/Conference proceedingChapter

Walkley, Steven U. / Lysosomal disorders of the nervous system. Neurobiology of Disease. Elsevier Inc., 2007. pp. 1-18
@inbook{45ef30923eff4e9cb8685f57624c0ab7,
title = "Lysosomal disorders of the nervous system",
abstract = "This chapter describes storage disorders, defines the key pathogenic features affecting neurons in these diseases, and discusses the links between the storage disorders and known functions of the greater lysosomal system. The classification of lysosomal storage disorders can be based on their clinicopathological features or their defective proteins. The molecular causes of lysosomal storage disorders are far more complex than the simple absence of an individual lysosomal enzyme and include defects in a wide variety of soluble and transmembrane proteins, some of which lack any known enzyme activity. Neurons undergoing lysosomal storage, demonstrate the presence of abnormal storage bodies, principally in perikarya and in larger dendrites. Another area of speculation in terms of pathogenic mechanisms affecting neurons in storage diseases involves ganglioside distribution in diseased cells and the possibility that the endosomal-lysosomal (E/L) system defect leads to an abnormal distribution of specific glycosphingolipids (GSLs) in internal membranes of cells. Changes in the GSL constituents of intracellular membranes may be due to the catabolic defects inherent in lysosomal diseases. Two other mechanisms that are emerging as critical players in the development of neurological disease in storage disorders are apoptosis and inflammation.",
author = "Walkley, {Steven U.}",
year = "2007",
doi = "10.1016/B978-012088592-3/50003-7",
language = "English (US)",
isbn = "9780120885923",
pages = "1--18",
booktitle = "Neurobiology of Disease",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Lysosomal disorders of the nervous system

AU - Walkley, Steven U.

PY - 2007

Y1 - 2007

N2 - This chapter describes storage disorders, defines the key pathogenic features affecting neurons in these diseases, and discusses the links between the storage disorders and known functions of the greater lysosomal system. The classification of lysosomal storage disorders can be based on their clinicopathological features or their defective proteins. The molecular causes of lysosomal storage disorders are far more complex than the simple absence of an individual lysosomal enzyme and include defects in a wide variety of soluble and transmembrane proteins, some of which lack any known enzyme activity. Neurons undergoing lysosomal storage, demonstrate the presence of abnormal storage bodies, principally in perikarya and in larger dendrites. Another area of speculation in terms of pathogenic mechanisms affecting neurons in storage diseases involves ganglioside distribution in diseased cells and the possibility that the endosomal-lysosomal (E/L) system defect leads to an abnormal distribution of specific glycosphingolipids (GSLs) in internal membranes of cells. Changes in the GSL constituents of intracellular membranes may be due to the catabolic defects inherent in lysosomal diseases. Two other mechanisms that are emerging as critical players in the development of neurological disease in storage disorders are apoptosis and inflammation.

AB - This chapter describes storage disorders, defines the key pathogenic features affecting neurons in these diseases, and discusses the links between the storage disorders and known functions of the greater lysosomal system. The classification of lysosomal storage disorders can be based on their clinicopathological features or their defective proteins. The molecular causes of lysosomal storage disorders are far more complex than the simple absence of an individual lysosomal enzyme and include defects in a wide variety of soluble and transmembrane proteins, some of which lack any known enzyme activity. Neurons undergoing lysosomal storage, demonstrate the presence of abnormal storage bodies, principally in perikarya and in larger dendrites. Another area of speculation in terms of pathogenic mechanisms affecting neurons in storage diseases involves ganglioside distribution in diseased cells and the possibility that the endosomal-lysosomal (E/L) system defect leads to an abnormal distribution of specific glycosphingolipids (GSLs) in internal membranes of cells. Changes in the GSL constituents of intracellular membranes may be due to the catabolic defects inherent in lysosomal diseases. Two other mechanisms that are emerging as critical players in the development of neurological disease in storage disorders are apoptosis and inflammation.

UR - http://www.scopus.com/inward/record.url?scp=33947606335&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947606335&partnerID=8YFLogxK

U2 - 10.1016/B978-012088592-3/50003-7

DO - 10.1016/B978-012088592-3/50003-7

M3 - Chapter

AN - SCOPUS:33947606335

SN - 9780120885923

SP - 1

EP - 18

BT - Neurobiology of Disease

PB - Elsevier Inc.

ER -